Los Angeles Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Los Angeles Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,380	Closed	-$432K	–	1527
2021 Q4	$432K	Buy	30,380 +12,250	+68%	+$212K	﹤0.01%	1076
2021 Q3	$420K	Sell	18,130 -1,570	-8%	-$37.1K	﹤0.01%	1139
2021 Q2	$490K	Sell	19,700 -700	-3%	-$18.8K	﹤0.01%	1172
2021 Q1	$572K	Buy	+20,400	New	+$736K	﹤0.01%	1162

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Los Angeles Capital Management's FMTX Position: Q1 2022 in Review

Los Angeles Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022, closing a stake of 30,380 shares — an estimated $432K sold.

Los Angeles Capital Management first reported a position in FMTX in Q1 2021 and held it in 4 quarters. The position peaked at $572K in Q1 2021. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

Los Angeles Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Los Angeles Capital Management sold 30,380 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $432K.
Los Angeles Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Los Angeles Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $572K in Q1 2021.
98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Los Angeles Capital Management's 13F filing for Q1 2022, filed 6 May 2022.